Benzoin, a TCM used for stroke treatment, exerts its effects through targets such as phosphodiesterase 4D (PDE4D), ACE, and transthyretin (TTR), as suggested by network pharmacology and molecular docking studies. This evidence concerns the gene PDE4D and stroke disorder.